| Patient | Lili Boulanger |
|---|---|
| Date of birth | 2004-08-21 |
| Identifiers | MRN HR-ET025-SYN; SSN (made up) 000-25-7731 |
| Document date | 2026-01-28 |
| Author | Thaddeus Nwankwo-Delacroix, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Suspected inflammatory bowel disease in a woman of 21 with four months of right lower abdominal pain, diarrhea, fevers, and weight loss, with iron deficiency anemia and a fecal calprotectin of 1240 ug/g. Ileocolonoscopy, MR enterography, and tuberculosis screening are being arranged. Please see her once they are done to confirm the diagnosis and plan treatment with her. [S]
Urgency: Urgent, within two weeks. [S]
Questions for the consultant:
Ms. Boulanger is seen at the request of Dr. Marchetti-Rowe with four months of right lower abdominal cramping, five or six loose stools a day with one at night, evening fevers, fatigue, and loss of 6 kg. The ileocolonoscopy five days ago showed deep longitudinal ulcers over 15 cm of the terminal ileum and patchy ulcers in the ascending and transverse colon with a spared rectum (SES-CD 14); MR enterography showed 18 cm of inflamed terminal ileum without stricture, fistula, or abscess. She has no perianal, joint, eye, or skin symptoms. She has never smoked. She was told directly that the findings show Crohn disease, a lifelong condition that can be controlled, and asked to hear the treatment choices with their trade-offs. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
5 later historical claims are omitted because they describe events after the index age. See the teaching note.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Acetaminophen 500 mg oral tablet, one or two tablets by mouth up to every 6 hours as needed for abdominal pain, no more than 3000 mg a day; no nonsteroidal anti-inflammatory drugs | One or two tablets up to every 6 hours as needed | Oral route | 2025-12-15 | active | S |
| Prednisone 20 mg oral tablet: 40 mg by mouth each morning, reduced by 5 mg each week over eight weeks, as a bridge until risankizumab takes effect | 40 mg each morning, tapering by 5 mg weekly | Oral route | 2026-01-28 to 2026-03-24 | completed | S |
| Cholecalciferol (vitamin D3) 2000 units oral tablet, one tablet by mouth once daily | One tablet once daily | Oral route | 2026-01-28 | active | S |
| Calcium carbonate 1250 mg (500 mg elemental calcium) oral tablet, one tablet by mouth once daily with food while on prednisone | One tablet daily with food | Oral route | 2026-01-28 to 2026-03-24 | completed | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Crohn disease of the terminal ileum and colon (ileocolitis), Montreal A2 L3 B1 without perianal disease, moderate to severe: deep ileal ulcers over 15 cm and patchy colonic ulcers, SES-CD 14, Harvey-Bradshaw Index 11; intestinal tuberculosis excluded by negative interferon-gamma release assay, normal chest X-ray, and biopsies negative for acid-fast bacilli, TB PCR, and mycobacterial culture; synthetic modern diagnosis linked to her documented chronic intestinal illness, whose historical diagnosis is not settled | active | confirmed | K50.80 | S — Synthetic diagnosis confirmed within the modern episode; her historical illness is documented (D), but whether it was intestinal tuberculosis or Crohn disease remains a retrospective interpretation (R) and is disputed. |
| Four months of crampy right lower abdominal pain, loose stools up to six times a day including at night, low-grade evening fevers, and loss of 6 kg; inflammatory markers raised; colonoscopy and small-bowel imaging booked | resolved | confirmed | R19.7 | S — Synthetic presenting concern at the index visit, superseded by the diagnosis; the documented symptoms of early 1915 are echoed (D). |
| Iron deficiency anemia from chronic intestinal blood loss and poor absorption (hemoglobin 10.6 g/dL, MCV 76, ferritin 9) | active | confirmed | D50.0 | S — Synthetic finding at presentation; corrected by intravenous iron. |
| Moderate protein-calorie malnutrition: BMI 17.6 after losing 6 kg (12 percent of body weight) in four months; albumin 3.3 g/dL | active | confirmed | E44.0 | S — Synthetic nutritional status at presentation; resolved with treatment and dietitian support. |
| Vitamin D deficiency (25-hydroxyvitamin D 18 ng/mL) | active | confirmed | E55.9 | S — Synthetic finding at presentation. |
Vital signs recorded on 2026-01-28; see the referring visit's Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Thin and tired; BMI 17.5 |
| Mouth | Two small aphthous ulcers inside the lower lip |
| Abdomen | Tender in the right lower quadrant with fullness but no discrete mass |
| Perianal | No fistula, abscess, or skin tags |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-01-28 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 8 | {score} | S | ||
| 2026-01-28 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 9 | {score} | S | ||
| 2026-01-28 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 18 | U/L | <=33 U/L | Normal | S |
| 2026-01-28 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 20 | U/L | <=32 U/L | Normal | S |
| 2026-01-28 | Bilirubin.total [Mass/volume] in Serum or Plasma | 0.4 | mg/dL | <=1.2 mg/dL | Normal | S |
| 2026-01-28 | DXA Lumbar spine [Z-score] Bone density | -1.4 | {Z-score} | A Z-score of -2.0 or below is below the expected range for age | Normal | S |
| 2026-01-28 | DXA Femur [Z-score] Bone density | -1.1 | {Z-score} | A Z-score of -2.0 or below is below the expected range for age | Normal | S |
Data reviewed: Ileocolonoscopy images and report; biopsy histology with acid-fast stain and TB PCR (mycobacterial culture pending); MR enterography; chest X-ray; interferon-gamma release assay; hepatitis B, hepatitis C, HIV, measles, and varicella serology; stool tests and celiac serology; blood counts, iron studies, CRP, albumin, vitamin D, and fecal calprotectin; Dr. Marchetti-Rowe's referral. [S]